LATAM Technology Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM Technology Reporter.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on February 20, 2026

Feb. 20, 2026

El Estándar Europeo PlanetAI Nature Space impulsa su Metodología de Palma, única del mundo, en Latinoamérica e Indonesia

EIN Presswire

Feb. 20, 2026

Helios Fairfax Partners Corporation Closes Amendment to Credit Facility

GlobeNewswire

Feb. 20, 2026

Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment

GlobeNewswire

Feb. 20, 2026

Constellation Software Inc. Announces Change to the Date of the Conference Call to Discuss Fourth Quarter Results

GlobeNewswire

Feb. 20, 2026

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire

Feb. 20, 2026

Equinox Gold Announces Filing of 2025 Audited Financial Statements

GlobeNewswire

Feb. 20, 2026

Ray Youssef Step Down as NoOnes CEO

EIN Presswire

Feb. 20, 2026

Bel Fuse Inc. Announces Regular Quarterly Cash Dividend on its Class A and Class B Shares

GlobeNewswire

Feb. 20, 2026

GreenBanana SEO celebrates 30th 5-star Google Review, Reinforcing Role as Best Generative Engine Optimization (GEO) Agency

GlobeNewswire

Feb. 20, 2026

iPower Reports Fiscal Q2 2026 Results and Completes Strategic Operating Reset

GlobeNewswire

Feb. 20, 2026

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Feb. 20, 2026

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Feb. 20, 2026

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Feb. 20, 2026

Foresight Announced ADS Ratio Change

GlobeNewswire

Feb. 20, 2026

Averin Capital Acquisition Corp. Completes $250,000,000 Initial Public Offering

GlobeNewswire

Feb. 20, 2026

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Feb. 20, 2026

Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates

GlobeNewswire

Feb. 20, 2026

Surge Copper Announces Berg Project Acceptance into BC Critical Minerals Office

GlobeNewswire

Feb. 20, 2026

Century Aluminum Company Statement on U.S. Supreme Court IEEPA Ruling

GlobeNewswire

Feb. 20, 2026

Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option

GlobeNewswire